About Bolder BioPath
Bolder BioPath is a Healthcare company based in Boulder (United States) founded in 2003, and was acquired by Inotiv in April 2021. Bolder BioPath is engaged in contract pharmacology and pathology services. It operates on a Professional Services model. The company has 47 employees. Bolder BioPath offers products and services including In Vivo Models, In Vitro Services, and Pathology Services. Its focus areas include Biotechnology and Preclinical Research. Its legal entity is Bolder BioPATH, Inc. Its competitors include InVivo Biosystems, PsychoGenics and Alpha Genesis; 1 of its 3 listed competitors has raised funding.
Company details
Bolder BioPath, an Inotiv company, is focused on contract pharmacology and pathology services, specializing in in vivo models for autoimmune and inflammation conditions such as Rheumatoid Arthritis and Inflammatory Bowel Disease. Services are provided across therapeutic areas including cardiovascular, neuroscience, and oncology. Preclinical data is generated to support drug development from discovery to INDNDA stages. Solutions encompass in vitro and ex vivo analyses, safety assessments, and toxicology studies. The company caters to pharmaceutical and biotech sectors with customized research models and consultative drug discovery programs.
- Headquarters Boulder, United States
- Employees 47
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bolderbiopath.com
- Social LinkedIn
- Acquired by Inotiv (Apr 2021)
- Legal Name Bolder Biopath, Inc.
Products & Services of Bolder BioPath
Bolder BioPath offers a comprehensive portfolio of products and services, including In Vivo Models, In Vitro Services, and Pathology Services.
In vivo models are provided for preclinical research.
In vitro solutions are offered for decision-making support.
Pathology assessments are conducted for various disease states.
Investors in Bolder BioPath
Bolder BioPath has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical development and regulatory services are provided by Inotiv. | 1974 | inotivco.com | Lafayette, United States |
Investor details for Bolder BioPath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bolder BioPath
2 dated milestones of Bolder BioPath across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Bolder BioPath is founded.
- Exit Acquired by Inotiv.
Competitors of Bolder BioPath
Bolder BioPath has 3 listed competitors in our database, 1 of them funded. They include InVivo Biosystems, PsychoGenics and Alpha Genesis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| psychogenics.com | 1999 | Tarrytown, United States | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | ||
| alphagenesisinc.com | 2003 | Yemassee, United States | 143 | Company offering primate models and services for preclinical drug discovery |
Detailed competitors of Bolder BioPath
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Bolder BioPath (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bolder BioPath
Bolder BioPath was founded in 2003.
Bolder BioPath is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Bolder BioPath has 47 employees.
Bolder BioPath, an Inotiv company, is focused on contract pharmacology and pathology services, specializing in in vivo models for autoimmune and inflammation conditions such as Rheumatoid Arthritis and Inflammatory Bowel Disease. Services are provided across therapeutic areas including cardiovascular, neuroscience, and oncology. Preclinical data is generated to support drug development from discovery to INDNDA stages. Solutions encompass in vitro and ex vivo analyses, safety assessments, and toxicology studies. The company caters to pharmaceutical and biotech sectors with customized research models and consultative drug discovery programs.
Bolder BioPath's top competitors include PsychoGenics, Alpha Genesis and InVivo Biosystems.
Bolder BioPath offers In Vivo Models, In Vitro Services, and Pathology Services.
Bolder BioPath has 1 investor. Key investors include Inotiv Co.
Bolder BioPath operates through Bolder Biopath, Inc..
Yes. Bolder BioPath was acquired by Inotiv in April 2021.